Which has better earnings & valuation, NTRA or GH?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Natera $2.31B 16.79 -$208.16M -$1.63 N/A Guardant Health $1.18B 18.02 -$416.28M -$3.49 N/A

Is NTRA or GH more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Natera -9.05% -14.74% -10.27% Guardant Health -38.33% N/A -25.40%

Does the media refer more to NTRA or GH?

In the previous week, Guardant Health had 3 more articles in the media than Natera. MarketBeat recorded 37 mentions for Guardant Health and 34 mentions for Natera. Guardant Health's average media sentiment score of 0.97 beat Natera's score of 0.67 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 17 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer GH or BTSG?

In the previous week, Guardant Health had 14 more articles in the media than BrightSpring Health Services. MarketBeat recorded 37 mentions for Guardant Health and 23 mentions for BrightSpring Health Services. Guardant Health's average media sentiment score of 0.97 beat BrightSpring Health Services' score of 0.91 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 17 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive BrightSpring Health Services 8 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to GH or FMS?

In the previous week, Guardant Health had 33 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 37 mentions for Guardant Health and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.78 beat Guardant Health's score of 0.97 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 17 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher earnings and valuation, GH or PACS?

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $1.18B 18.02 -$416.28M -$3.49 N/A PACS Group $5.43B 1.31 $191.54M $1.56 28.77

Does the media refer more to GH or PACS?

In the previous week, Guardant Health had 29 more articles in the media than PACS Group. MarketBeat recorded 37 mentions for Guardant Health and 8 mentions for PACS Group. PACS Group's average media sentiment score of 1.16 beat Guardant Health's score of 0.97 indicating that PACS Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 17 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer GH or HIMS?

In the previous week, Guardant Health had 10 more articles in the media than Hims & Hers Health. MarketBeat recorded 37 mentions for Guardant Health and 27 mentions for Hims & Hers Health. Guardant Health's average media sentiment score of 0.97 beat Hims & Hers Health's score of 0.22 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 17 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 5 Very Positive mention(s) 3 Positive mention(s) 11 Neutral mention(s) 5 Negative mention(s) 3 Very Negative mention(s) Neutral

Guardant Health (GH) Competitors

$160.82 -1.17 (-0.72%)

As of 01:36 PM Eastern

Compare

GH vs. NTRA, BTSG, FMS, PACS, and HIMS

Should you buy Guardant Health stock or one of its competitors? MarketBeat compares Guardant Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Guardant Health include Natera (NTRA), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), PACS Group (PACS), and Hims & Hers Health (HIMS).

How does Guardant Health compare to Natera?

Natera (NASDAQ:NTRA) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	16.79	-$208.16M	-$1.63	N/A
Guardant Health	$1.18B	18.02	-$416.28M	-$3.49	N/A

Natera has a beta of 1.51, suggesting that its stock price is 51% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.59, suggesting that its stock price is 59% more volatile than the broader market.

In the previous week, Guardant Health had 3 more articles in the media than Natera. MarketBeat recorded 37 mentions for Guardant Health and 34 mentions for Natera. Guardant Health's average media sentiment score of 0.97 beat Natera's score of 0.67 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	23 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	17 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Natera currently has a consensus target price of $267.83, suggesting a potential downside of 0.96%. Guardant Health has a consensus target price of $179.82, suggesting a potential upside of 11.81%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	2 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	3 Strong Buy rating(s)	2.82
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.96

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Guardant Health	-38.33%	N/A	-25.40%

99.9% of Natera shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.1% of Natera shares are held by insiders. Comparatively, 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Guardant Health beats Natera on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to BrightSpring Health Services?

Guardant Health (NASDAQ:GH) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

BrightSpring Health Services has a net margin of 2.55% compared to Guardant Health's net margin of -38.33%. BrightSpring Health Services' return on equity of 16.73% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
BrightSpring Health Services	2.55%	16.73%	5.24%

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$1.18B	18.02	-$416.28M	-$3.49	N/A
BrightSpring Health Services	$14.37B	0.83	$190.67M	$1.66	36.51

Guardant Health presently has a consensus target price of $179.82, indicating a potential upside of 11.81%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 16.68%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts clearly believe BrightSpring Health Services is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.96
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	3.00

Guardant Health has a beta of 1.59, indicating that its share price is 59% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market.

In the previous week, Guardant Health had 14 more articles in the media than BrightSpring Health Services. MarketBeat recorded 37 mentions for Guardant Health and 23 mentions for BrightSpring Health Services. Guardant Health's average media sentiment score of 0.97 beat BrightSpring Health Services' score of 0.91 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	17 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	8 Very Positive mention(s)	1 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats Guardant Health on 10 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, Guardant Health had 33 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 37 mentions for Guardant Health and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.78 beat Guardant Health's score of 0.97 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	17 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Guardant Health presently has a consensus price target of $179.82, indicating a potential upside of 11.81%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.95, indicating a potential downside of 5.38%. Given Guardant Health's stronger consensus rating and higher possible upside, research analysts plainly believe Guardant Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.96
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$1.18B	18.02	-$416.28M	-$3.49	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.61	$1.11B	$1.90	13.32

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -38.33%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Guardant Health has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

Summary

Guardant Health beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to PACS Group?

Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

PACS Group has a net margin of 4.49% compared to Guardant Health's net margin of -38.33%. PACS Group's return on equity of 26.47% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
PACS Group	4.49%	26.47%	4.36%

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Guardant Health presently has a consensus target price of $179.82, indicating a potential upside of 11.81%. PACS Group has a consensus target price of $50.60, indicating a potential upside of 12.74%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.96
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, Guardant Health had 29 more articles in the media than PACS Group. MarketBeat recorded 37 mentions for Guardant Health and 8 mentions for PACS Group. PACS Group's average media sentiment score of 1.16 beat Guardant Health's score of 0.97 indicating that PACS Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	17 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$1.18B	18.02	-$416.28M	-$3.49	N/A
PACS Group	$5.43B	1.31	$191.54M	$1.56	28.77

Guardant Health has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market.

Summary

PACS Group beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Hims & Hers Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Guardant Health currently has a consensus price target of $179.82, indicating a potential upside of 11.81%. Hims & Hers Health has a consensus price target of $31.43, indicating a potential upside of 2.40%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts clearly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.96
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Guardant Health has a beta of 1.59, meaning that its stock price is 59% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market.

Hims & Hers Health has a net margin of -0.56% compared to Guardant Health's net margin of -38.33%. Hims & Hers Health's return on equity of 6.10% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has higher revenue and earnings than Guardant Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$1.18B	18.02	-$416.28M	-$3.49	N/A
Hims & Hers Health	$2.37B	3.00	$128.37M	-$0.09	N/A

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Guardant Health had 10 more articles in the media than Hims & Hers Health. MarketBeat recorded 37 mentions for Guardant Health and 27 mentions for Hims & Hers Health. Guardant Health's average media sentiment score of 0.97 beat Hims & Hers Health's score of 0.22 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	17 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	5 Very Positive mention(s)	3 Positive mention(s)	11 Neutral mention(s)	5 Negative mention(s)	3 Very Negative mention(s)	Neutral

Summary

Guardant Health beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GH vs. The Competition

Export

Metric	Guardant Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$21.33B	$9.97B	$6.80B	$12.67B
Dividend Yield	N/A	2.54%	2.59%	10.03%
P/E Ratio	-46.08	25.65	282.15	25.05
Price / Sales	18.02	5.52	571.19	79.42
Price / Cash	N/A	26.44	28.64	34.82
Price / Book	-203.58	5.24	11.03	6.18
Net Income	-$416.28M	$312.25M	$3.49B	$347.72M
7 Day Performance	10.56%	-0.04%	0.31%	0.64%
1 Month Performance	-4.26%	-0.70%	-4.41%	-3.82%
1 Year Performance	288.28%	27.42%	62.76%	20.08%

Guardant Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GH Guardant Health	3.0582 of 5 stars	$160.83 -0.7%	$179.82 +11.8%	+291.1%	$21.33B	$1.18B	N/A	2,506	Analyst Forecast Gap Down
NTRA Natera	2.7492 of 5 stars	$258.03 -1.5%	$267.83 +3.8%	+99.0%	$37.52B	$2.31B	N/A	6,140	Upcoming Earnings
BTSG BrightSpring Health Services	4.9027 of 5 stars	$71.98 -1.3%	$70.12 -2.6%	+204.0%	$14.38B	$12.91B	51.05	23,500	Positive News Earnings Report Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	3.842 of 5 stars	$24.90 +1.3%	$28.00 +12.4%	+2.2%	$13.21B	$22.20B	13.11	1,488	Positive News Upcoming Earnings
PACS PACS Group	3.5397 of 5 stars	$46.95 +0.2%	$50.60 +7.8%	+334.3%	$7.42B	$5.29B	30.09	47,455	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GH) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, PACS, and HIMS

How does Guardant Health compare to Natera?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Guardant Health compare to PACS Group?

Summary

How does Guardant Health compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, PACS, and HIMS

How does Guardant Health compare to Natera?

Which has better earnings & valuation, NTRA or GH?

Which has more risk and volatility, NTRA or GH?

Does the media refer more to NTRA or GH?

Do analysts rate NTRA or GH?

Is NTRA or GH more profitable?

Do institutionals and insiders have more ownership in NTRA or GH?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Do insiders & institutionals believe in GH or BTSG?

Is GH or BTSG more profitable?

Which has better earnings & valuation, GH or BTSG?

Do analysts prefer GH or BTSG?

Which has more volatility and risk, GH or BTSG?

Does the media prefer GH or BTSG?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Does the media refer more to GH or FMS?

Do analysts prefer GH or FMS?

Which has better valuation & earnings, GH or FMS?

Is GH or FMS more profitable?

Do insiders & institutionals believe in GH or FMS?

Which has more risk and volatility, GH or FMS?

Summary

How does Guardant Health compare to PACS Group?

Is GH or PACS more profitable?

Do institutionals and insiders believe in GH or PACS?

Do analysts prefer GH or PACS?

Does the media refer more to GH or PACS?

Which has higher earnings and valuation, GH or PACS?

Which has more volatility and risk, GH or PACS?

Summary

How does Guardant Health compare to Hims & Hers Health?

Do analysts prefer GH or HIMS?

Which has more volatility & risk, GH or HIMS?

Is GH or HIMS more profitable?

Which has stronger valuation and earnings, GH or HIMS?

Do institutionals & insiders believe in GH or HIMS?

Does the media prefer GH or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools